FDA
-
-
-
-
-
-
-
Engene Holdings Inc. (ENGN) PT Lowered to $4 at H.C. Wainwright
-
-
-
-
-
-
-
enGene changes name to enGene Therapeutics as it nears commercialization
-
-
-
-
-
-
-
enGene Reports Full Year 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
enGene Named a BioSpace 2026 Best Places to Work Winner
-
-
-
-
-
-
-
enGene adds three board members and promotes executives for commercialization
-
-
-
-
-
-
-
enGene Names Amy Pott as Chief Global Commercialization Officer
-
-
-
-
-
-
-
enGene Reports Second Quarter 2024 Financial Results and Provides a Business Update
-
334,274 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


